6-122789368-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006714.5(SMPDL3A):āc.22G>Cā(p.Val8Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,547,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006714.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMPDL3A | NM_006714.5 | c.22G>C | p.Val8Leu | missense_variant | 1/8 | ENST00000368440.5 | NP_006705.1 | |
SMPDL3A | NM_001286138.2 | c.-158G>C | 5_prime_UTR_variant | 1/7 | NP_001273067.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMPDL3A | ENST00000368440.5 | c.22G>C | p.Val8Leu | missense_variant | 1/8 | 1 | NM_006714.5 | ENSP00000357425.4 | ||
SMPDL3A | ENST00000539041 | c.-158G>C | 5_prime_UTR_variant | 1/7 | 2 | ENSP00000442152.1 | ||||
SMPDL3A | ENST00000487215.1 | n.77G>C | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000209 AC: 3AN: 143672Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 77352
GnomAD4 exome AF: 0.0000122 AC: 17AN: 1395640Hom.: 0 Cov.: 30 AF XY: 0.0000131 AC XY: 9AN XY: 688360
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.22G>C (p.V8L) alteration is located in exon 1 (coding exon 1) of the SMPDL3A gene. This alteration results from a G to C substitution at nucleotide position 22, causing the valine (V) at amino acid position 8 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at